Radical Cystectomy (RC) Versus Bladder Preservation Therapy (BPT) for Muscle-invasive Bladder Cancer
Justin E. Bekelman(University of Pennsylvania Health System), Nandita Mitra(University of Pennsylvania), David J. Vaughn(University of Pennsylvania), John P. Christodouleas(Elekta (Sweden)), Craig Evan Pollack(Johns Hopkins University), Daniel Polsky(Johns Hopkins University), Elizabeth Handorf(University of Pennsylvania), Thomas J. Guzzo(Hospital of the University of Pennsylvania), Matthew J. Resnick(Vanderbilt University Medical Center), Samuel Swisher‐McClure(University of Pennsylvania)
International Journal of Radiation Oncology*Biology*Physics
October 25, 2012
Cited by 0
Related Papers
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects
|Journal of Clinical Oncology|2007|799
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688